Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H20O7 |
| Molecular Weight | 372.3686 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C(OC)=C(OC)C(OC)=C3OC
InChI
InChIKey=ULSUXBXHSYSGDT-UHFFFAOYSA-N
InChI=1S/C20H20O7/c1-22-12-8-6-11(7-9-12)14-10-13(21)15-16(23-2)18(24-3)20(26-5)19(25-4)17(15)27-14/h6-10H,1-5H3
| Molecular Formula | C20H20O7 |
| Molecular Weight | 372.3686 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Tangeretin is an O-polymethoxylated flavone that is found in tangerine and other citrus peels. Its natural role is to strengthen the cell wall and act as a plant's defensive mechanism against disease-causing pathogens. Animal studies have shown the potential fo tangeretin as a therapeutic in a number of conditions including cancers, asthma, CKD, hypercholesterolemia, and Parkinson's disease.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28501723 | https://www.ncbi.nlm.nih.gov/pubmed/11726811
Curator's Comment: referenced study was conducted in rat
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P42574 Gene ID: 836.0 Gene Symbol: CASP3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/23137376 |
|||
Target ID: GO:0014065 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28501723 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro effects of some flavones on human pyruvate kinase isoenzyme M2. | 2015-03 |
|
| Tangeretin ameliorates oxidative stress in the renal tissues of rats with experimental breast cancer induced by 7,12-dimethylbenz[a]anthracene. | 2014-09-02 |
|
| Polyphenols and human health: prevention of disease and mechanisms of action. | 2010-11 |
|
| Antioxidant enrichment and antimicrobial protection of fresh-cut fruits using their own byproducts: looking for integral exploitation. | 2010-10 |
|
| Isolation and identification of polymethoxyflavones from the hybrid Citrus, hallabong. | 2010-09-08 |
|
| Simultaneous determination of flavonoids in different parts of Citrus reticulata 'Chachi' fruit by high performance liquid chromatography-photodiode array detection. | 2010-08-05 |
|
| Evaluation of the effect of lime fruit juice on the anticoagulant effect of warfarin. | 2010-07 |
|
| Inhibitory effects of 5-hydroxy polymethoxyflavones on colon cancer cells. | 2010-07 |
|
| Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework. | 2010-06-15 |
|
| Use of silkworms for identification of drug candidates having appropriate pharmacokinetics from plant sources. | 2010-06-11 |
|
| The flavonoid tangeretin activates the unfolded protein response and synergizes with imatinib in the erythroleukemia cell line K562. | 2010-06 |
|
| Polymethoxylated flavones, flavanone glycosides, carotenoids, and antioxidants in different cultivation types of tangerines ( Citrus reticulata Blanco cv. Sainampueng) from Northern Thailand. | 2010-05-26 |
|
| Semisynthesis of natural flavones inhibiting tubulin polymerization, from hesperidin. | 2010-04-23 |
|
| Induction of apoptosis in human cervical carcinoma HeLa cells by polymethoxylated flavone-rich Citrus grandis Osbeck (Dangyuja) leaf extract. | 2010-03-20 |
|
| Managing phenol contents in crop plants by phytochemical farming and breeding-visions and constraints. | 2010-03-02 |
|
| Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. | 2010-03 |
|
| Flavonoids from the stems of Croton caudatus Geisel. var. tomentosus Hook. | 2010-02-26 |
|
| [Study on the contents of flavonoids in Citrus reticulata 'Chachi' from various habitats and different collecting periods]. | 2010-02 |
|
| Hepatoprotective effects of flavonoids from shekwasha (Citrus depressa) against D-galactosamine-induced liver injury in rats. | 2010 |
|
| Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. | 2009-12-01 |
|
| Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. | 2009-11-18 |
|
| Fingerprinting alterations of secondary metabolites of tangerine peels during growth by HPLC-DAD and chemometric methods. | 2009-09-01 |
|
| UPLC/Q-TOFMS/MS as a powerful technique for rapid identification of polymethoxylated flavones in Fructus aurantii. | 2009-08-15 |
|
| Exogenous Cx43 expression decrease cell proliferation rate in rat hepatocarcinoma cells independently of functional gap junction. | 2009-08-13 |
|
| Simultaneous determination of five bioactive flavonoids in pericarpium Citri reticulatae from china by high-performance liquid chromatography with dual wavelength detection. | 2009-08-12 |
|
| Semisynthesis and antiproliferative evaluation of a series of 3'-aminoflavones. | 2009-07-01 |
|
| Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention. | 2009-06-16 |
|
| [Reparative isolation and purification of flavones from Pericarpium Citri Reticulatae by high-speed counter-current chromatography]. | 2009-03 |
|
| Synthesis and biological evaluation of a series of tangeretin-derived chalcones. | 2009-01-01 |
|
| Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. | 2008-09-10 |
|
| Suppressive Effects of Selected Food Phytochemicals on CD74 Expression in NCI-N87 Gastric Carcinoma Cells. | 2008-09 |
|
| Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. | 2008-07-09 |
|
| Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. | 2008-03-15 |
|
| Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. | 2008-03-15 |
|
| Plant polyphenolics as anti-invasive cancer agents. | 2008-02 |
|
| Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. | 2008-01 |
|
| Validated reversed phase LC method for quantitative analysis of polymethoxyflavones in citrus peel extracts. | 2008-01 |
|
| Inhibition of oral carcinogenesis by citrus flavonoids. | 2008 |
|
| Inhibitory effects of various beverages on human recombinant sulfotransferase isoforms SULT1A1 and SULT1A3. | 2007-12 |
|
| Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. | 2007-11 |
|
| Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? | 2007-10 |
|
| Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. | 2007-10 |
|
| Antimicrobial activity of wax and hexane extracts from Citrus spp. peels. | 2007-09 |
|
| Biotransformation of polymethoxylated flavonoids: access to their 4'-O-demethylated metabolites. | 2007-06 |
|
| Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways. | 2007-06 |
|
| Quality control and discrimination of pericarpium citri reticulatae and pericarpium citri reticulatae viride based on high-performance liquid chromatographic fingerprints and multivariate statistical analysis. | 2007-04-11 |
|
| Correlation between flavonoid content and the NO production inhibitory activity of peel extracts from various citrus fruits. | 2007-04 |
|
| Chemopreventive effects of orange peel extract (OPE). II: OPE inhibits atypical hyperplastic lesions in rodent mammary gland. | 2007-03 |
|
| Chemopreventive effects of orange peel extract (OPE). I: OPE inhibits intestinal tumor growth in ApcMin/+ mice. | 2007-03 |
|
| Suppressive effects of demethylated metabolites of nobiletin on phorbol ester-induced expression of scavenger receptor genes in THP-1 human monocytic cells. | 2007 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28871498
CKD was induced in Sprague-Dawley rats by 5/6 nephrectomy (Nx). Separated groups of 5/6 Nx rats were treated intragastrically with tangeretin (50, 100 or 200 mg/kg bw) or enalapril for 30 days, starting 5 days after the surgery. Elevated TNF-α, nitric oxide (NO) and cytokines-IL-6 and IL-1β with upregulated NF-κB/TNF-α/iNOS signaling pathways were effectively down-regulated by tangeretin. Cognitive disturbances and memory impairments observed in Nx rats were substantially improved by tangeretin. Collectively, the experimental data indicate that the anti-oxidant and anti-inflammatory effects of tangeretin effectively improved renal function and reduced the cognitive and memory impairments in CKD-induced animals.
Route of Administration:
Intragastric
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/23137376
Human colorectal adenocarcinoma cell line, LoVo, and its resistant subline, LoVo/Dx, obtained by prolonged exposure to doxorubicin were cultivated in Ham's F12 medium at 37 deg-C and an atmosphere of 5% CO2 (with addition of 10% fetal bovine serum, L-glutamine, antibiotics, and in the case of loVo/Dx cells, doxorubicin at 100 ng/mL). Cells were seeded in 96-well plates in 75 micro-L of medium and allowed to attach for 60 min at 37 deg-C. An equal volume of medium containing Tangeretin was added, and the incubation was continued for 72 hours. Cytotoxicity was monitored using a sulforhodamine B assay. Tangeretin demonstrated the greatest cytotoxicity among studied compounds in both LoVo, and LoVo/Dx cells with an IC50 range between 20 - 40 microM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:16:18 GMT 2025
by
admin
on
Mon Mar 31 18:16:18 GMT 2025
|
| Record UNII |
I4TLA1DLX6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C68464
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID30197417
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
I4TLA1DLX6
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
53909
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
68077
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
C68468
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
207-570-1
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
300000037347
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
9400
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
C059006
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
TANGERITIN
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
481-53-8
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
I4TLA1DLX6
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY | |||
|
618905
Created by
admin on Mon Mar 31 18:16:18 GMT 2025 , Edited by admin on Mon Mar 31 18:16:18 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
48% Cell growth rate of mouse myeloid leukemia M1 cells at 50 uM of compound vs control
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
26% Cell growth rate of human acute promyelocytic leukemia HL-60 cells at 50 uM of compound vs control
|
||
|
TRANSPORTER -> INHIBITOR |
|